News
Therapy for rare cancers: NCT scientists from Heidelberg and Dresden receive the Paul Martini Prize
Joint press release by the NCT Heidelberg and the NCT/UCC Dresden
Information, support, exchange: Virtual encounters at the 17th Heidelberg CancerPatient Day
On Saturday, April 2, 2022, this year's Heidelberg CancerPatient Day was once again held as a...
New members in the Managing Directorate
The managing directorate of the National Center for Tumor Diseases (NCT) Heidelberg is expanding and...
NCT Patient Advisory Board reorganized
In November 2021, the NCT Patient Advisory Board at the National Center for Tumor Diseases (NCT)...
NCT Events: Retrospect 2021
More than 40 events and seminars, around 5,000 participants – in 2021 we were able to offer you a...
Tracking down resistant cancer cells
Press release by the German Cancer Research Center
Corona rapid testing in day clinics 1 and 2 No accompanying persons are allowed in Day Clinic 1...
Press release from DKFZ
With the aim of better understanding the enabling and limiting factors regarding staying or...
Sarcomas are rare mesenchymal malignancies arising from connective tissues as well as bones and...